http://www.fda.gov/cder/orange/appendix_a.txt
ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
20508S005_Lac-Hydrin (Ammonium Lactate) Cream
Food and Drug Administration Center for Drug Evaluation and Research Approval Package Search Lac -Hydrin (Ammonium Lactate) Cream Company:--Bristol Myers Squibb Company Application No.:--20-508/S005 Approval Date:-8/25/2000 - Approval Letter(s) - Printed Labeling - Medical Review(s) - Chemistry Review(s) - Pharmacology Review(s) - Statistical Review(s)...
author: Paul Stauffer
Paddock Laboratories, Inc. - Other RX's
BACITRACIN USP STERILE BELLADONNA & OPIUM SUPPOSITORIES COLISTIN SULFATE USP POWDER COLOCORT® Hydrocortisone Rectal Suspension, USP (Retention) COMPRO™ Prochlorperazine Suppositories, USP 25mg DEXAMETHASONE SODIUM PHOSPHATE USP POWDER HYDROCORTISONE ACETATE USP MICRONIZED POWDER HYDROCORTISONE ACETATE SUPPOSITORIES (Hemorrhoidal HC Suppositories) HYDROCORTISONE USP...
OGD, First Time Approvals - May 2002
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search First-Time Generics - May 2002 Generic Drug Name Generic Manufacturer Brand Name Approval Date 1- IDARUBICIN HYDROCHLORIDE FOR INJECTION, USP 5 MG, 10 MG, AND 20 MG SINGLE-DOSE VIALS GENSIA SICOR PHARMACEUTICALS, INC IDAMYCIN FOR INJECTION 5/1/02 2- AMMONIUM LACTATE ...
author: OGD
CDER Template - Replace Title Here
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search First-Time Generics - June 2002 - Generic Drug Name Generic Manufacturer Brand Name Approval Date- 1- AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, U 200 MG/28.5 MG (BASE)/5 ML, AND 400 MG/57 MG (BASE)/5 ML GENEVA PHARMACEUTICALS, INC AUGMENTIN 200 MG/5 ML AND AUGMENTIN...
author: USERNAME
Paddock Laboratories, Inc. - Dermatology
AQUABASE™ (Anhydrous Hydrophilic Ointment) BENZOIN COMPOUND TINCTURE USP DERMABASE™ (Oil-in-Water Emulsion Base) HYDROCREAM BASE™ (Water-in-Oil Cream Base) LAClotion™ 12% (Ammonium Lactate) Lotion LANOLIN USP (Anhydrous) LIQUA-GEL™ Aqueous Gel Vehicle LIQUA-GEL™, PUMPS FOR NYSTOP® nystatin topical powder, USP PODOCON-25® (25%...
Paddock Laboratories, Inc. - Diabetes
GLUTOL™ (Contains: 100 gm Dextrose/180 mL prepared for the performance of the Glucose Tolerance Test) GLUTOSE 15™ (Oral Glucose Gel for Hypoglycemia) Free Patient Education Materials on Hypoglycemia GLUTOSE 45™(Oral Glucose Gel for Hypoglycemia) LAClotion™ 12% (Ammonium Lactate) Lotion PADDOCK NEWS Secundum Artem TM Now available in PDF form NEW...
Paddock Laboratories, Inc. - Key Products
Master Product List Actidose® Activated Charcoal Colocort® Hydrocortisone Rectal Suspension Compounding Actives, Vehicles, Stability Studies Compro™ Prochlorperazine Suppositories Encort™ Hydrocortisone Acetate Suppositories 30 mg Dihydroergotamine Mesylate Injection, USP EZ-Char™ Activated Charcoal USP Glutose™ For Hypoglycemia FREE Patient Education...
Prescription and OTC Drug Product List 6/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -D- AA PEACHTREE 500MG;10MG N40210 001 AUG 13, 1997 JUN CAHN -A- AA UCB 500MG;10MG N40210 001 AUG 13, 1997 JUN CAHN ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE TABLET; ORAL DARVOCET -A- @ AAIPHARMA LLC 325MG;32.5MG N16844 001 JUN CAHN -D- @...
Prescription and OTC Drug Product List 5/2002
2 -D- + ROBINS AH 325MG;15MG N84444 001 MAY DISC -A- @ 325MG;15MG N84444 001 MAY DISC SOLUTION; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE -D- AA ALPHARMA 120MG/5ML;12MG/5ML N85861 001 MAY CRLD -A- AA + 120MG/5ML;12MG/5ML N85861 001 MAY CRLD TYLENOL W/ CODEINE -D- AA + JOHNSON RW 120MG/5ML;12MG/5ML N85057 001 MAY DISC -A- @ 120MG/5ML;12MG/5ML N85057 001 MAY DISC TABLET; ORAL...
Laclotion sell sheet
** Lac - Hydrin ® is a registered trademark of Westwood- Squibb Pharmaceuticals, Inc LAClotion 12% Lotion is available in: ° 225 g plastic bottle NDC 0574- 2021- 08 ° 400 g plastic bottle NDC 0574- 2021- 16 LAClotion TM 12% Lotion is the only AB Rated substitute product for Lac - Hydrin ® 12% Lotion P A D D O C K T O P I C A L S...
author: george_haeger
Laclotion sell sheet page 2
author: george_haeger
Prescription and OTC Drug Product List 10/1998
Prescription and Over-the-Counter Drug Product List - 18th Edition Cumulative Supplement Number 10: October 1998 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE BENZYL PENICILLOYL-POLYLYSINE CAPSULE; ORAL INJECTABLE; INJECTION BUTALBITAL, ACETAMINOPHEN AND CAFFEINE PRE-PEN - ADD - AB WEST WARD 500MG;50MG;40MG N40261...
PDPL
PRESCRIPTION DRUG PRODUCT LIST- 16TH EDITION RX DRUG PRODUCT LIST / CUMULATIVE SUPPLEMENT NUMBER 8 / JAN'96 - AUG'96 ACETAMINOPHEN; BUTALBITAL ALPRAZOLAM TABLET; ORAL TABLET; ORAL BUTALBITAL AND ACETAMINOPHEN ALPRAZOLAM - DLT - AB HALSEY 325MG;50MG N89568 001 - ADD - AB NOVOPHARM 2MG N74085 004 - DLT - OCT 05, 1988 - ADD - FEB 26, 1996 - ADD - @ 325MG;50MG N89568 001 - ADD - OCT 05,...
FDA Drug Approvals List August 2000
Original Application #: 021197 Approval Date: 11-AUG-00 Trade Name: CETROTIDE Chemical Type: 1 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: ASTA MEDICA INC Active Ingredient(s): CETRORELIX OTC/RX Status: RX Indication(s): For the prevention of premature LH surges in women undergoing controlled ovarian stimulation Original Application #: 021128 Approval Date: 01-AUG-00...
DDPA August 1996
DEPARTMENT OF HEALTH AND HUMAN SERVICES, PUBLIC HEALTH SERVICE NDA NUMBER TRADE NAME APPLICANT ACTIVE INGREDIENT(S) APPROVAL DATE (DOSAGE FORM) STRENGTH(S) (CLASSIFICATION) CLASSIFICATION(S) ***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS 19-640 HUMATROPE LILLY SOMATROPIN, BIOSYNTHETIC 01-AUG-96 (INJECTABLE) INDIANAPOLIS, IN 5MG/VIAL (SUPPL-013) 45285 (NEW INDICATION --...
August Drug Approvals
Original Application #: 020508 Approval Date: 29-AUG-96 Trade Name: LAC -HYDRIN Chemical Type: 3 Therapeutic Potential: S Dosage Form: CREAM Applicant: BRISTOL MYERS CO Active Ingredient(s): AMMONIUM LACTATE OTC/RX Status: RX Indication(s): ICHTHYOSIS VULGARIS AND XEROSIS Original Application #: 020532 Approval Date: 26-AUG-96 Trade Name: IVY BLOCK Chemical...
Pediatric Exclusivity Labeling Changes
Food and Drug Administration Center for Drug Evaluation and Research Pediatrics Search Pediatric Exclusivity Labeling Changes as of February 6, 2004 - - Exclusivity Granted (Labeled) Product Indications Label Changes 1 10/1/99 (8/25/00) Ammonium lactate - Lac -Hydrin (Westwood-Squibb) Label [PDF ] Xerosis, ichthyosis Safety and effectiveness established in...
Laclotion sell sheet page 1
author: george_haeger
http://www.fda.gov/cder/pediatric/labels/AmmonLactate.pdf
Rx only LAC - HYDRIN 12%* (ammonium lactate cream) Cream For Dermatologic use only DESCRIPTION: *LAC - HYDRIN is a formulation of 12% lactic acid neutralized with ammonium hydroxide, as ammonium lactate with a pH of 4.4 5.4LAC - HYDRIN Cream also contains water, light mineral oil, glyceryl stearate, polyoxyl 100 stearate,...
http://www.fda.gov/cder/pediatric/labels/AmmonLactate.pdf page 2
duplicates:http://www.fda.gov/cder/foi/label/2000/20508S5lbl.pdf
http://www.fda.gov/cder/pediatric/labels/AmmonLactate.pdf page 1
duplicates:http://www.fda.gov/cder/foi/label/2000/20508S5lbl.pdf
http://www.fda.gov/cder/foi/label/2000/20508S5lbl.pdf
Rx only LAC - HYDRIN 12%* (ammonium lactate cream) Cream For Dermatologic use only DESCRIPTION: *LAC - HYDRIN is a formulation of 12% lactic acid neutralized with ammonium hydroxide, as ammonium lactate with a pH of 4.4 5.4LAC - HYDRIN Cream also contains water, light mineral oil, glyceryl stearate, polyoxyl 100 stearate,...
http://www.fda.gov/cder/foi/appletter/2000/20508S5ltr.pdf
NDA 20- 508/ S- 005 Bristol- Myers Squibb Company Attention: David Silberstein Director, Worldwide Regulatory Affairs P Silberstein: Please refer to your supplemental new drug application dated August 24, 1999, received August 26, 1999, submitted under section 505( b) of the Federal Food, Drug, and Cosmetic Act for Lac - Hydrin (ammonium lactate cream) Cream, 12%...
http://www.fda.gov/cder/foi/appletter/2000/20508S5ltr.pdf page 1